-
-
-
-
-
-
-
Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024
-
-
-
-
-
-
-
Kintara Therapeutics (KTRA) to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc.
-
-
-
-
-
-
-
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor
-
-
-
-
-
-
-
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
-
-
-
-
-
-
-
Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Proactive news headlines including PharmaDrug, Forian, Alpine 4 Holdings and Else Nutrition
-
-
-
-
-
-
-
Proactive news headlines including Esports Entertainment Group, Unigold, ElectraMeccanica Vehicles Corp and Bam Bam Resources
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

